leisure time -WSS

leisure time

author：entertainment 2025-09-30 01:14:07 - browse：15

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration said Monday that it has deep reservations about NurOwn, an investigational ALS treatment from BrainStorm Cell Therapeutics, citing a lack of evidence that the medicine works and the company’s failure to demonstrate that it can properly manufacture the product.

In documents disclosed ahead of a Wednesday public hearing on NurOwn’s application for approval, the FDA detailed its problems with a clinical trial that missed its primary objective and noted that BrainStorm submitted “grossly deficient” information on how the medicine is made, voicing “major concerns that the available data do not meet the statutory standard of substantial evidence of effectiveness to support” approval.

BrainStorm filed for approval over the FDA’s protest, insisting that NurOwn has demonstrated benefits for a subset of ALS patients with milder disease. That conclusion, based on an after-the-fact analysis of the company’s failed pivotal trial, has proved polarizing among patients and physicians, with some arguing that the FDA should exercise flexibility in light of the irrevocably fatal nature of ALS and others demanding BrainStorm conduct another clinical trial to demonstrate its benefits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

WSS

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

U.K. researchers warn about biases in medical devices, algorithms

Methadone treatment changes are coming. Do they go far enough?

Neuroscience’s long legacy of racism

New research casts further doubt on a common procedure used with IVF

Argenx readies a blockbuster opportunity with drug for autoimmune disease

focus

leisure time

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Continuity nursing helped my family in our darkest PICU moments

New research casts further doubt on a common procedure used with IVF

Wildfire smoke exposes gaps in outdoor worker protections

Baby aspirin cuts fat buildup in liver disease patients, in small study

How to save PrEP access — and even expand it

California’s proposed $25 per hour health care minimum wage

New air purifier tech could be key to improving indoor air quality

Baby aspirin cuts fat buildup in liver disease patients, in small study

explore

U.K. researchers warn about biases in medical devices, algorithms

Lecanemab for Alzheimer's is coming. Is the health system ready?

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

How the political right came to back psychedelics to treat trauma

App could help diagnose ear infections more accurately — and at home

Why 40% Americans with Parkinson’s don’t see a neurologist

Wikipedia

Wikipedia

hotspot

hotspot